HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762,505 | +8.4% | 8,512 | +3.0% | 0.61% | +12.1% |
| Q2 2023 | $703,427 | -4.0% | 8,262 | -6.7% | 0.55% | -3.9% |
| Q1 2023 | $732,834 | +6.1% | 8,856 | +0.8% | 0.57% | -7.9% |
| Q4 2022 | $690,862 | -8.3% | 8,784 | -13.7% | 0.62% | -10.8% |
| Q3 2022 | $753,000 | -4.3% | 10,174 | -15.7% | 0.69% | -6.1% |
| Q2 2022 | $787,000 | -8.1% | 12,073 | -10.8% | 0.74% | +5.6% |
| Q1 2022 | $856,000 | +37.6% | 13,534 | +15.5% | 0.70% | +30.0% |
| Q4 2021 | $622,000 | – | 11,720 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |